# Filing Detail

Form ARS - Annual Report to Security Holders:
SEC Accession No. 0001213900-23-085309
Filing Date
2023-11-09
Accepted
2023-11-09 17:09:59
Documents
1
Period of Report
2022-12-31
Effectiveness Date
2023-11-09

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | FORM ARS | fars2023_actiniumpharm.pdf | ARS | 607082
| Complete submission text file | 0001213900-23-085309.txt |  | 832456

Mailing Address 100 PARK AVE., 23RD FLOOR NEW YORK NY 10017
Business Address 100 PARK AVE., 23RD FLOOR NEW YORK NY 10017 (646) 677-3870
Actinium Pharmaceuticals, Inc. (Filer) CIK: 0001388320 (see all company filings)

EIN.: 880378336 | State of Incorp.: DE | Fiscal Year End: 1231
Type: ARS | Act: 34 | File No.: 001-36374 | Film No.: 231393703
SIC: 2834 Pharmaceutical Preparations